Geopolitics Alpha

Market closed · last trade · ETF proxies, Alpaca IEX

Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch

Published . Updated .

Key takeaways

  • The record breaking Anthropic IPO has thrown fresh spotlight on high risk, high reward sectors that hinge on research and intellectual property.
  • Exposed: ANT, LLY, JNJ, PFE, MRK
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch

The record breaking Anthropic IPO has thrown fresh spotlight on high risk, high reward sectors that hinge on research and intellectual property. Canadian biotech stocks sit squarely in that camp, with science driven pipelines that can react very differently to broad market

Directly affected

  • ANT Anthropic, PBC

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.

  • EWC iShares MSCI Canada ETF+2.5% 30d

    iShares MSCI Canada ETF holds stocks listed in Canada, which this story is about (“canadian”).

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • PFE Pfizer+5.2% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • MRK Merck+3.5% 30d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
ANTNo price data for this ticker———————
XLV+6.43%+4.39%baseafter closeafter closeafter closeafter close
XBI+4.51%+0.86%baseafter closeafter closeafter closeafter close
EWC+6.81%+4.37%baseafter closeafter closeafter closeafter close
LLY+6.91%+4.75%baseafter closeafter closeafter closeafter close
JNJ+7.01%+4.30%baseafter closeafter closeafter closeafter close
PFE+4.82%+3.23%baseafter closeafter closeafter closeafter close
MRK+11.32%+8.02%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch Yahoo Finance

Source: Yahoo Finance

Price since this story was published: Select Sector Spdr Tr (XLV)

CompanyWhenMoveStatus
Ishares Msci Canada Etf (EWC)three days earlier+4.37%final price
Ishares Msci Canada Etf (EWC)five days earlier+6.81%final price
Johnson & Johnson (JNJ)three days earlier+4.30%final price
Johnson & Johnson (JNJ)five days earlier+7.01%final price
Eli Lilly (LLY)three days earlier+4.75%final price
Eli Lilly (LLY)five days earlier+6.91%final price
Merck (MRK)three days earlier+8.02%final price
Merck (MRK)five days earlier+11.32%final price
Pfizer (PFE)three days earlier+3.23%final price
Pfizer (PFE)five days earlier+4.82%final price
Spdr Series Trust (XBI)three days earlier+0.86%final price
Spdr Series Trust (XBI)five days earlier+4.51%final price
Select Sector Spdr Tr (XLV)three days earlier+4.39%final price
Select Sector Spdr Tr (XLV)five days earlier+6.43%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Select Sector Spdr Tr (XLV)

Companies tied to this story

  • XLV Select Sector Spdr Tr

    In “Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story

  • XBI Spdr Series Trust

    For “Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch,” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story

  • EWC Ishares Msci Canada Etf

    In “Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch,” Ishares Msci Canada Etf (EWC) is linked, with no stored direction, medium confidence. Reason on file: iShares MSCI Canada ETF holds stocks listed in Canada, which this story is about (“canadian”)

  • LLY Eli Lilly

    For “Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story

  • JNJ Johnson & Johnson

    For “Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch,” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story

  • PFE Pfizer

    In “Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story

  • MRK Merck

    For “Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch,” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story

Select Sector Spdr Tr (XLV)

“Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch” (19 Nov 2026) reaches Select Sector Spdr Tr (XLV) through this story.

Select Sector Spdr Tr (XLV) is on the page because Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story

Also listed, Spdr Series Trust (XBI): SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story

The price range for Select Sector Spdr Tr (XLV), and the dates in the story

EWC traded between 57.81 and 61.73 across 20 sessions. The latest close on file is 60.20.

How strong the case is around Select Sector Spdr Tr (XLV)

46 out of 100

“Medexus Pharmaceuticals And 2 Other Canadian Biotech Stocks To Watch” scores 46 out of 100. The score uses 1 source, and 7 linked companies.